Plavsic Mark
SEC insider (Form 3/4/5 filer). CIK 0001868719. Chief Technology Officer at Aura Biosciences, Inc. (AURA). 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in BOSTON, MA.
Companies Plavsic Mark has filed insider reports for
- Aura Biosciences, Inc. (AURA): Officer, Chief Technology Officer
Plavsic Mark
CIK: 0001868719
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AURA
Aura Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 2, 2026AURA
Aura Biosciences, Inc.
AwardDirect62.3K shares- - Feb 17, 2026AURA
Aura Biosciences, Inc.
SaleDirect15.9K shares at avg. $5.05$80K - Oct 16, 2025AURA
Aura Biosciences, Inc.
SaleDirect12.2K shares at avg. $6.35$77K - Feb 18, 2025AURA
Aura Biosciences, Inc.
SaleDirect2.2K shares at avg. $7.75$17K - Feb 3, 2025AURA
Aura Biosciences, Inc.
AwardDirect90.5K shares- - Oct 16, 2024AURA
Aura Biosciences, Inc.
SaleDirect7.4K shares at avg. $9.85$73K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | AURA Aura Biosciences, Inc. | Award | 62,339 | - | $0 | Direct |
| Feb 17, 2026 | AURA Aura Biosciences, Inc. | Sale | 15,890 | $5.05 | $80,245 | Direct |
| Oct 16, 2025 | AURA Aura Biosciences, Inc. | Sale | 12,169 | $6.35 | $77,273 | Direct |
| Feb 18, 2025 | AURA Aura Biosciences, Inc. | Sale | 2,151 | $7.75 | $16,670 | Direct |
| Feb 3, 2025 | AURA Aura Biosciences, Inc. | Award | 90,475 | - | - | Direct |
| Oct 16, 2024 | AURA Aura Biosciences, Inc. | Sale | 7,383 | $9.85 | $72,723 | Direct |
1-6 of 6 transactions